Hema Biologics, LLC
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$1.9Mgeneral payments (2019-2025)
$194Kresearch payments (2019-2025)
289clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Guy Young | Bozeman, MT | Pediatric Hematology-Oncology | $261,919.99 |
| Doris Quon | Los Angeles, CA | Hematology (Internal Medicine) | $183,785.77 |
| Tammuella Chrisentery-Singleton | New Orleans, LA | Pediatric Hematology-Oncology | $165,110.61 |
| Steven Pipe | Ann Arbor, MI | Pediatric Hematology-Oncology | $141,868.38 |
| Miguel Escobar | Houston, TX | Hematology (Internal Medicine) | $135,987.80 |
| Wiliam Alexander | Austin, TX | General Practice | $114,183.54 |
| Robert Sidonio | Atlanta, GA | Pediatric Hematology-Oncology | $84,595.03 |
| Adam Giermasz | Sacramento, CA | Hematology & Oncology | $57,196.66 |
| Maissaa Janbain | New Orleans, LA | Hematology & Oncology | $44,279.94 |
| Amy Dunn | Columbus, OH | Pediatric Hematology-Oncology | $41,245.14 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.